Shandong Weigao Group Medical Polymer Co Ltd (SHWGY)
2.62
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Shandong Weigao Group Medical Polymer Total Liabilities (Quarterly): 1.365B for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.365B |
June 30, 2023 | 1.428B |
June 30, 2023 | 1.428B |
December 31, 2022 | 1.423B |
June 30, 2022 | 1.539B |
June 30, 2022 | 1.539B |
December 31, 2021 | 1.495B |
June 30, 2021 | 1.491B |
June 30, 2021 | 1.491B |
December 31, 2020 | 1.390B |
June 30, 2020 | 1.156B |
June 30, 2020 | 1.156B |
December 31, 2019 | 1.338B |
June 30, 2019 | 1.286B |
June 30, 2019 | 1.286B |
Date | Value |
---|---|
December 31, 2018 | 1.279B |
June 30, 2018 | 1.229B |
June 30, 2018 | 1.229B |
December 31, 2017 | 481.35M |
June 30, 2017 | 550.60M |
December 31, 2016 | 511.29M |
June 30, 2016 | 472.03M |
December 31, 2015 | 420.90M |
June 30, 2015 | 514.68M |
June 30, 2014 | 365.05M |
June 30, 2013 | 280.40M |
June 30, 2012 | 197.38M |
June 30, 2011 | 159.95M |
June 30, 2010 | 160.63M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.156B
Minimum
Jun 2020
1.539B
Maximum
Jun 2022
1.387B
Average
1.423B
Median
Dec 2022
Total Liabilities (Quarterly) Benchmarks
Sinovac Biotech Ltd | 1.635B |
CASI Pharmaceuticals Inc | 51.10M |
Zai Lab Ltd | 226.27M |
Gracell Biotechnologies Inc (DELISTED) | 36.85M |
Adagene Inc | 45.17M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 4.750B |
Shareholders Equity (Quarterly) | 3.167B |
Debt to Equity Ratio | 0.1801 |
Current Ratio | 2.458 |
Net Debt Paydown Yield | 0.62% |